27-hydroxycholesterol has been researched along with Thyroid Cancer, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baila-Rueda, L; Blanco, RM; Carles Escolà-Gil, J; Cenarro, A; Corcoy, R; de Leiva, A; Faria, MDS; Fuste, V; García-León, A; González, C; Ignacio Pérez, J; Lerma, E; Magalhaes, M; Mato, E; Moral, A; Pons, MP; Revilla, G; Sabé, G; Santos, D | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Thyroid Cancer, Anaplastic
| Article | Year |
|---|---|
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Papillary; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholestanetriol 26-Monooxygenase; Cholesterol, LDL; Cytochrome P450 Family 7; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Male; MAP Kinase Signaling System; Middle Aged; Phosphatidylinositol 3-Kinases; Receptors, LDL; Steroid Hydroxylases; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; TOR Serine-Threonine Kinases; Young Adult | 2019 |